5 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio

Page 1 of 5

In this article, we discuss the 5 best biotech stocks under $20 in Cathie Wood’s portfolio. If you want to read our detailed analysis of these stocks, go directly to 10 Best Biotech Stocks Under $20 in Cathie Wood’s Portfolio.

5. Cerus Corporation (NASDAQ:CERS)

Number of Hedge Fund Holders: 17

Share price as of November 24: $7.17

Cerus Corporation (NASDAQ:CERS) supplies tech-powered blood systems to hospitals and blood centers. The company’s product is available in the US, Canada, Asia, Europe, Africa, and the Middle East. 

The California-based company is one of the cheapest biotech stocks in Cathie Wood’s portfolio. ARK Investment Management owned 17 million shares of Cerus Corporation (NASDAQ:CERS) worth more than $104 million at the end of the September quarter. Cerus Corporation (NASDAQ:CERS) represents 0.24% of ARK’s funds.

The biotech company’s revenue climbed 44% year over year to $42.1 million in the third quarter of 2021. The company saw increased sales of its INTERCEPT platelet products in the US. Cerus Corporation (NASDAQ:CERS) stock jumped 17.5% on November 3 after the company raised its sales forecast for 2021 to $127 million to $129 million from $118 million to $122 million.

By the end of the third quarter, 17 hedge funds had a $244 million stake in Cerus Corporation (NASDAQ:CERS), compared to 19 in the previous quarter with a $249 million stake.

Page 1 of 5